{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T23:39:10Z","timestamp":1770766750795,"version":"3.50.0"},"reference-count":200,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11926-024-01179-0","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T02:45:51Z","timestamp":1737945951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fast, Present and Future of the Concept of Spondyloarthritis"],"prefix":"10.1007","volume":"27","author":[{"given":"J.","family":"Braun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"issue":"5","key":"1179_CR1","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1136\/ard-2023-225185","volume":"83","author":"D van der Heijde","year":"2024","unstructured":"van der Heijde D, Molto A, Ramiro S, Braun J, Dougados M, van Gaalen FA, Gensler LS, Inman RD, Landew\u00e9 RBM, Marzo-Ortega H, Navarro-Comp\u00e1n V, Phoka A, Poddubnyy D, Protopopov M, Reveille J, Rudwaleit M, Sampaio-Barros P, Sepriano A, Sieper J, Van den Bosch FE, van der Horst-Bruinsma I, Machado PM, Baraliakos X. Goodbye to the term \u201cankylosing spondylitis\u201d, hello \u201caxial spondyloarthritis\u201d: time to embrace the ASAS-defined nomenclature. Ann Rheum Dis. 2024;83(5):547\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"9570","key":"1179_CR2","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"J Braun","year":"2007","unstructured":"Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007;369(9570):1379\u201390.","journal-title":"Lancet"},{"issue":"9783","key":"1179_CR3","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","volume":"377","author":"M Dougados","year":"2011","unstructured":"Dougados M, Baeten D. Spondyloarthritis. Lancet. 2011;377(9783):2127\u201337.","journal-title":"Lancet"},{"issue":"10089","key":"1179_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","volume":"390","author":"J Sieper","year":"2017","unstructured":"Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet. 2017;390(10089):73\u201384.","journal-title":"Lancet"},{"issue":"1","key":"1179_CR5","doi-asserted-by":"publisher","first-page":"15013","DOI":"10.1038\/nrdp.2015.13","volume":"9","author":"J Sieper","year":"2015","unstructured":"Sieper J, Braun J, Dougados M, Baeten D. Axial spondyloarthritis. Nat Rev Dis Primers. 2015;9(1):15013.","journal-title":"Nat Rev Dis Primers"},{"key":"1179_CR6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S van der Linden","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361\u20138.","journal-title":"Arthritis Rheum"},{"issue":"4 Suppl 55","key":"1179_CR7","first-page":"S3","volume":"27","author":"TG Benedek","year":"2009","unstructured":"Benedek TG. How did ankylosing spondylitis become a separate disease\u202f? Clin Exp Rheumatol. 2009;27(4 Suppl 55):S3-9.","journal-title":"Clin Exp Rheumatol"},{"key":"1179_CR8","unstructured":"Roentgen C. Ueber eine neue Art von Strahlen. (Vorl\u00e4ufige Mittheilung). In: Aus den Sitzungsberichten der W\u00fcrzburger Physik.-medic. Gesellschaft W\u00fcrzburg. Verlag der Stahel\u2019-schen k. Hof- u. Universit\u00e4ts-Buch- u. Kunsthandlung, W\u00fcrzburg. Dezember 1895, S. 137\u2013147; weitere Auflagen 1896."},{"key":"1179_CR9","first-page":"537","volume":"50","author":"W Krebs","year":"1934","unstructured":"Krebs W. Das R\u00f6ntgenbild des Beckens bei der Bechterew\u2019schen Krankheit. Fortschr a d Geb d R\u00f6ntgenstr. 1934;50:537.","journal-title":"Fortschr a d Geb d R\u00f6ntgenstr"},{"issue":"2","key":"1179_CR10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1699-0463.1940.tb01475.x","volume":"17","author":"E Waaler","year":"1940","unstructured":"Waaler E. On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscules. Acta Pathol Microbiol Scand. 1940;17(2):172\u201388.","journal-title":"Acta Pathol Microbiol Scand"},{"issue":"1","key":"1179_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3181\/00379727-68-16375","volume":"68","author":"HM Rose","year":"1948","unstructured":"Rose HM, Ragan C, Pierce E, Lipman MO. Differential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis. Proc Soc Exp Biol Med. 1948;68(1):1\u20136.","journal-title":"Proc Soc Exp Biol Med"},{"key":"1179_CR12","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/00005792-197409000-00002","volume":"53","author":"JMH Moll","year":"1974","unstructured":"Moll JMH, Haslock I, Macrae I, Wright V. Associations between ankylosing spondylitis, psoriatic arthritis, Reiters\u2019 disease, the intestinal arthropathies, and Behcet\u2019s syndrome. Med (Baltimore). 1974;53:343\u201364.","journal-title":"Med (Baltimore)"},{"issue":"12","key":"1179_CR13","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrrheum.2015.147","volume":"11","author":"D McGonagle","year":"2015","unstructured":"McGonagle D, Aydin SZ, G\u00fcl A, Mahr A, Direskeneli H. \u2019MHC-I-opathy\u2019-unified concept for spondyloarthritis and Beh\u00e7et disease. Nat Rev Rheumatol. 2015;11(12):731\u201340.","journal-title":"Nat Rev Rheumatol"},{"key":"1179_CR14","unstructured":"Kellgren JH, Jeffrey MR, Ball J. The epidemiology of chronic rheumatism. Vol 1. Oxford. Blackwell scientific publications. 1963; 326\u2013327"},{"key":"1179_CR15","unstructured":"Population studies of the rheumatic diseases; proceedings of the third international symposium, New York, June 5th-10th, 1966. Bennett PH, Wood PHN, eds. National Institute of Arthritis and Metabolic Diseases (U.S.), Excerpta Medica Foundation."},{"issue":"6","key":"1179_CR16","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1136\/ard.62.6.519","volume":"62","author":"A van Tubergen","year":"2003","unstructured":"van Tubergen A, Heuft-Dorenbosch L, Schulpen G, Landew\u00e9 R, Wijers R, van der Heijde D, van Engelshoven J, van der Linden S. Radiographic assessment of sacroiliitis by radiologists and rheumatologists: does training improve quality? Ann Rheum Dis. 2003;62(6):519\u201325.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1179_CR17","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1136\/ard.32.4.354","volume":"32","author":"JM Moll","year":"1973","unstructured":"Moll JM, Wright V. New York clinical criteria for ankylosing spondylitis. Stat Eval Ann Rheum Dis. 1973;32(4):354\u201363.","journal-title":"Stat Eval Ann Rheum Dis"},{"key":"1179_CR18","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/S0140-6736(73)91360-3","volume":"1","author":"DA Brewerton","year":"1973","unstructured":"Brewerton DA, Caffrey M, Hart FD, et al. Ankylosing spondylitis and HL-A27. Lancet. 1973;1:904\u20137.","journal-title":"Lancet"},{"key":"1179_CR19","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1056\/NEJM197304052881403","volume":"288","author":"L Schlosstein","year":"1973","unstructured":"Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen, W27 with ankylosing spondylitis. N Engl J Med. 1973;288:704\u20136.","journal-title":"N Engl J Med"},{"key":"1179_CR20","doi-asserted-by":"crossref","unstructured":"Wellcome Trust Case Control Consortium; Australo-Anglo-American Spondylitis Consortium (TASC); Burton PR, Brown M. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007; 39 (11):1329\u201337","DOI":"10.1038\/ng.2007.17"},{"issue":"8","key":"1179_CR21","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/ng.873","volume":"43","author":"DM Evans","year":"2011","unstructured":"Evans DM, Spencer CC, Pointon JJ, et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet. 2011;43(8):761\u20137 (Erratum in: Nat Genet 2011 Sep; 43(9): 919).","journal-title":"Nat Genet"},{"issue":"1","key":"1179_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.7326\/0003-4819-96-1-70","volume":"96","author":"MA Khan","year":"1982","unstructured":"Khan MA, Khan MK. Diagnostic value of HLA-B27 testing ankylosing spondylitis and Reiter\u2019s syndrome. Ann Intern Med. 1982;96(1):70\u20136.","journal-title":"Ann Intern Med"},{"key":"1179_CR23","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/art.1780341003","volume":"34","author":"M Dougados","year":"1991","unstructured":"Dougados M, Van Der Linden S, Juhlin R, et al. The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum. 1991;34:1218.","journal-title":"Arthritis Rheum"},{"key":"1179_CR24","first-page":"85","volume":"57","author":"B Amor","year":"1990","unstructured":"Amor B, Dougados M, Mijiyawa M. Criteria of the classification of spondylarthropathies. Rev Rhum Mal Osteoartic. 1990;57:85\u20139.","journal-title":"Rev Rhum Mal Osteoartic"},{"issue":"6","key":"1179_CR25","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F, Gu J, Khan MA, Kirazli Y, Maksymowych WP, Mielants H, S\u00f8rensen IJ, Ozgocmen S, Roussou E, Valle-O\u00f1ate R, Weber U, Wei J, Sieper J. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777\u201383 (Erratum in: Ann Rheum Dis 2019 Jun; 78(6): e59).","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"1179_CR26","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1136\/ard-2023-224434","volume":"82","author":"Z Li","year":"2023","unstructured":"Li Z, Khan MK, van der Linden SM, Winkens B, Villiger PM, Baumberger H, van Zandwijk H, Khan MA, Brown MA. HLA-B27, axial spondyloarthritis and survival. Ann Rheum Dis. 2023;82(12):1558\u201367.","journal-title":"Ann Rheum Dis"},{"issue":"24","key":"1179_CR27","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1001\/jama.1977.03270510035017","volume":"237","author":"A Calin","year":"1977","unstructured":"Calin A, Porta J, Fries JF, Schurman DJ. Clinical history as a screening test for ankylosing spondylitis. JAMA. 1977;237(24):2613\u20134.","journal-title":"JAMA"},{"issue":"1","key":"1179_CR28","doi-asserted-by":"publisher","first-page":"e002302","DOI":"10.1136\/rmdopen-2022-002302","volume":"8","author":"Z Li","year":"2022","unstructured":"Li Z, van der Linden SM, Khan MA, Baumberger H, Zandwijk HV, Khan MK, Villiger PM, Brown MA. Heterogeneity of axial spondyloarthritis: genetics, sex and structural damage matter. RMD Open. 2022;8(1):e002302.","journal-title":"RMD Open"},{"issue":"1","key":"1179_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1136\/annrheumdis-2013-204055","volume":"74","author":"S Ramiro","year":"2015","unstructured":"Ramiro S, Stolwijk C, van Tubergen A, van der Heijde D, Dougados M, van den Bosch F, Landew\u00e9 R. Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study. Ann Rheum Dis. 2015;74(1):52\u20139 (Erratum in: Ann Rheum Dis 2015 Jul; 74 (7): 1482).","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1179_CR30","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1136\/ard.2003.011247","volume":"63","author":"M Rudwaleit","year":"2004","unstructured":"Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J. How to diagnose axial spondylo-arthritis early. Ann Rheum Dis. 2004;63(5):535\u201343.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1179_CR31","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1136\/annrheumdis-2016-210119","volume":"76","author":"Z Ez-Zaitouni","year":"2017","unstructured":"Ez-Zaitouni Z, Bakker PAC, van Lunteren M, Berg IJ, Landew\u00e9 R, van Oosterhout M, Lorenzin M, van der Heijde D, van Gaalen FA. Presence of multiple spondyloarthritis (SpA) features is impor-tant but not sufficient for a diagnosis of axial spondyloarthritis: data from the SPondyloArthritis Caught Early (SPACE) cohort. Ann Rheum Dis. 2017;76(6):1086\u201392.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1179_CR32","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1093\/rheumatology\/key035","volume":"57","author":"Z Ez-Zaitouni","year":"2018","unstructured":"Ez-Zaitouni Z, Landew\u00e9 R, van Lunteren M, Bakker PA, Fagerli KM, Ramonda R, Jacobsson LTH, van der Heijde D, van Gaalen FA. Imaging of the sacroiliac joints is important for diagnosing early axial spondyloarthritis but not all-decisive. Rheumatology (Oxford). 2018;57(7):1173\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"1179_CR33","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1136\/ard-2023-224959","volume":"83","author":"ML Marques","year":"2024","unstructured":"Marques ML, Ramiro S, van Lunteren M, Stal RA, Landew\u00e9 RB, van de Sande M, Fagerli KM, Berg IJ, van Oosterhout M, Exarchou S, Ramonda R, van der Heijde D, van Gaalen FA. Can rheumatolo-gists unequivocally diagnose axial spondyloarthritis in patients with chronic back pain of less than 2 years duration? Primary outcome of the 2-year SPondyloArthritis Caught Early (SPACE) cohort. Ann Rheum Dis. 2024;83(5):589\u201398.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1179_CR34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/00002281-199507000-00001","volume":"7","author":"MA Khan","year":"1995","unstructured":"Khan MA. HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol. 1995;7(4):263\u20139.","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"1179_CR35","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1055\/s-0031-1272531","volume":"136","author":"C Neumann-Haefelin","year":"2011","unstructured":"Neumann-Haefelin C. Protektiver Effekt von HLA-B27 auf den Verlauf der HIV- und Hepatitis-C-Virus-Infektion [Protective role of HLA-B27 in HIV and hepatitis C virus infection]. Dtsch Med Wochenschr. 2011;136(7):320\u20134.","journal-title":"Dtsch Med Wochenschr"},{"key":"1179_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev-immunol-032414-112110","volume":"33","author":"P Bowness","year":"2015","unstructured":"Bowness P. HLA-B27. Annu Rev Immunol. 2015;33:29\u201348.","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"1179_CR37","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/art.1780370709","volume":"37","author":"J Braun","year":"1994","unstructured":"Braun J, Bollow M, Eggens U, K\u00f6nig H, Distler A, Sieper J. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum. 1994;37(7):1039\u201345.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1179_CR38","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0889-857X(05)70038-7","volume":"24","author":"J Braun","year":"1998","unstructured":"Braun J, Bollow M, Sieper J. Radiologic diagnosis and pathology of the spondyloarthropathies. Rheum Dis Clin North Am. 1998;24(4):697\u2013735.","journal-title":"Rheum Dis Clin North Am"},{"issue":"9","key":"1179_CR39","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.3899\/jrheum.130141","volume":"40","author":"D Poddubnyy","year":"2013","unstructured":"Poddubnyy D, Gaydukova I, Hermann KG, Song IH, Haibel H, Braun J, Sieper J. Magnetic resonance imaging compared to conventional radiographs for detection of chronic structural changes in sacroiliac joints in axial spondyloarthritis. J Rheumatol. 2013;40(9):1557\u201365.","journal-title":"J Rheumatol"},{"issue":"11","key":"1179_CR40","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1136\/ard-2022-222986","volume":"81","author":"D Poddubnyy","year":"2022","unstructured":"Poddubnyy D, Diekhoff T, Baraliakos X, Hermann KGA, Sieper J. Diagnostic evaluation of the sacroiliac joints for axial spondyloarthritis: should MRI replace radiography? Ann Rheum Dis. 2022;81(11):1486\u201390.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1179_CR41","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1136\/annrheumdis-2019-215589","volume":"78","author":"WP Maksymowych","year":"2019","unstructured":"Maksymowych WP, Lambert RG, \u00d8stergaard M, Pedersen SJ, Machado PM, Weber U, Bennett AN, Braun J, Burgos-Vargas R, de Hooge M, Deodhar AA, Eshed I, Jurik AG, Hermann KA, Landew\u00e9 RB, Marzo-Ortega H, Navarro-Comp\u00e1n V, Poddubnyy D, Reijnierse M, Rudwaleit M, Sieper J, Van den Bosch FE, van der Heijde D, van der Horst-Bruinsma IE, Wichuk S, Baraliakos X. MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group. Ann Rheum Dis. 2019;78(11):1550\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"1179_CR42","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1136\/annrheumdis-2021-222081","volume":"81","author":"X Baraliakos","year":"2022","unstructured":"Baraliakos X, \u00d8stergaard M, Lambert RG, Eshed I, Machado PM, Pedersen SJ, Weber U, de Hooge M, Sieper J, Poddubnyy D, Rudwaleit M, van der Heijde D, Landew\u00e9 RB, Maksymowych WP. MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working group. Ann Rheum Dis. 2022;81(9):1243\u201351.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1179_CR43","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, CASPAR Study Group. Mielants H Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665\u201373.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1179_CR44","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1136\/annrheumdis-2021-221422","volume":"81","author":"J Braun","year":"2022","unstructured":"Braun J, Landew\u00e9 RB. No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related \u201cphysician-reported spondylitis\u201d? Ann Rheum Dis. 2022;81(4):466\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"13","key":"1179_CR45","doi-asserted-by":"publisher","first-page":"1759720X2110579","DOI":"10.1177\/1759720X211057975","volume":"18","author":"D Poddubnyy","year":"2021","unstructured":"Poddubnyy D, Baraliakos X, Van den Bosch F, Braun J, Coates LC, Chandran V, Diekhoff T, van Gaalen FA, Gensler LS, Goel N, Gottlieb AB, van der Heijde D, Helliwell PS, Hermann KGA, Jadon D, Lambert RG, Maksymowych WP, Mease P, Nash P, Proft F, Protopopov M, Sieper J, Torgutalp M, Gladman DD. Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Ther Adv Musculoskelet Dis. 2021;18(13):1759720X211057975.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"1179_CR46","unstructured":"The CLassification of Axial SpondyloarthritiS Inception Cohort (CLASSIC). ClinicalTrials.gov ID\u00a0NCT03993847."},{"issue":"5","key":"1179_CR47","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1136\/annrheumdis-2015-208852","volume":"75","author":"A Deodhar","year":"2016","unstructured":"Deodhar A, Strand V, Kay J, Braun J. The term \u201cnon-radiographic axial spondyloarthritis\u201d is much more important to classify than to diagnose patients with axial spondyloarthritis. Ann Rheum Dis. 2016;75(5):791\u20134.","journal-title":"Ann Rheum Dis"},{"key":"1179_CR48","doi-asserted-by":"crossref","unstructured":"Braun J. Why the term nr-axSpA should not be used for diagnosis. Ann Rheum Dis 2024, in press","DOI":"10.1016\/j.ard.2024.11.003"},{"issue":"1","key":"1179_CR49","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/annrheumdis-2013-204231","volume":"73","author":"R Landew\u00e9","year":"2014","unstructured":"Landew\u00e9 R, Braun J, Deodhar A, Dougados M, Maksymowych WP, Mease PJ, Reveille JD, Rudwaleit M, van der Heijde D, Stach C, Hoepken B, Fichtner A, Coteur G, de Longueville M, Sieper J. Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study. Ann Rheum Dis. 2014;73(1):39\u201347.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1179_CR50","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/ard.2010.133645","volume":"70","author":"M Rudwaleit","year":"2011","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, Akkoc N, Brandt J, Chou CT, Dougados M, Huang F, Gu J, Kirazli Y, Van den Bosch F, Olivieri I, Roussou E, Scarpato S, S\u00f8rensen IJ, Valle-O\u00f1ate R, Weber U, Wei J, Sieper J. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2011;70(1):25\u201331.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1179_CR51","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1136\/annrheumdis-2016-210747","volume":"76","author":"A Sepriano","year":"2017","unstructured":"Sepriano A, Rubio R, Ramiro S, Landew\u00e9 R, van der Heijde D. Performance of the ASAS classifi-cation criteria for axial and peripheral spondyloarthritis: a systematic literature review and meta-analysis. Ann Rheum Dis. 2017;76(5):886\u201390.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1179_CR52","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1136\/annrheumdis-2019-216516","volume":"79","author":"A Sepriano","year":"2020","unstructured":"Sepriano A, Ramiro S, van der Heijde D, van Gaalen F, Hoonhout P, Molto A, Saraux A, Ramonda R, Dougados M, Landew\u00e9 R. What is axial spondyloarthritis? A latent class and transition analysis in the SPACE and DESIR cohorts. Ann Rheum Dis. 2020;79(3):324\u201331 (Erratum in: Ann Rheum Dis 2020 Jun; 79 (6): e78).","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1179_CR53","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1093\/rheumatology\/keab887","volume":"61","author":"AS De Craemer","year":"2022","unstructured":"De Craemer AS, Renson T, Deroo L, Van Praet L, Cypers H, Varkas G, Joos R, Devinck M, Gysel-brecht L, Peene I, Thevissen K, Costantino F, D\u2019Agostino MA, Lenaerts J, Carron P, Van den Bosch F, Elewaut D. Peripheral manifestations are major determinants of disease phenotype and outcome in new onset spondyloarthritis. Rheumatology (Oxford). 2022;61(8):3279\u201388 (Erratum in: Rheumatology (Oxford) 2023 Oct 06: kead529).","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"1179_CR54","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1093\/rheumatology\/keab873","volume":"61","author":"F Costantino","year":"2022","unstructured":"Costantino F, Aegerter P, Schett G, De Craemer AS, Molto A, Van den Bosch F, Elewaut D, Breban M, D\u2019Agostino MA. Cluster analysis in early axial spondyloarthritis predicts poor outcome in the presence of peripheral articular manifestations. Rheumatology (Oxford). 2022;61(8):3289\u201398.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1179_CR55","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/annrheumdis-2013-203582","volume":"74","author":"C Stolwijk","year":"2015","unstructured":"Stolwijk C, van Tubergen A, Castillo-Ortiz JD, Boonen A. Prevalence of extra-articular manife-stations in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74(1):65\u201373.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1179_CR56","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13075-016-1093-z","volume":"18","author":"JJ de Winter","year":"2016","unstructured":"de Winter JJ, van Mens LJ, van der Heijde D, Landew\u00e9 R, Baeten DL. Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis. Arthritis Res Ther. 2016;18(1):196.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"1179_CR57","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/gut.42.3.387","volume":"42","author":"TR Orchard","year":"1998","unstructured":"Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut. 1998;42(3):387\u201391.","journal-title":"Gut"},{"issue":"2","key":"1179_CR58","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S0016-5085(00)70209-5","volume":"118","author":"TR Orchard","year":"2000","unstructured":"Orchard TR, Thiyagaraja S, Welsh KI, Wordsworth BP, Hill Gaston JS, Jewell DP. Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology. 2000;118(2):274\u20138.","journal-title":"Gastroenterology"},{"issue":"5","key":"1179_CR59","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/rheumatology\/30.5.339","volume":"30","author":"P Helliwell","year":"1991","unstructured":"Helliwell P, Marchesoni A, Peters M, Barker M, Wright V. A re-evaluation of the osteoarticular manifestations of psoriasis. Br J Rheumatol. 1991;30(5):339\u201345.","journal-title":"Br J Rheumatol"},{"issue":"1","key":"1179_CR60","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/ard.2006.054288","volume":"66","author":"PS Helliwell","year":"2007","unstructured":"Helliwell PS, Porter G, Taylor WJ, CASPAR Study Group. Polyarticular psoriatic arthritis is more like oligoarticular psoriatic arthritis, than rheumatoid arthritis. Ann Rheum Dis. 2007;66(1):113\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1179_CR61","first-page":"962","volume":"85","author":"FI Lee","year":"1990","unstructured":"Lee FI, Bellary SV, Francis C. Increased occurrence of psoriasis in patients with Crohn\u2019s disease and their relatives. Am J Gastroenterol. 1990;85(8):962\u20133.","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"1179_CR62","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1136\/annrheumdis-2012-202143","volume":"72","author":"WQ Li","year":"2013","unstructured":"Li WQ, Han JL, Chan AT, Qureshi AA. Psoriasis, psoriatic arthritis and increased risk of incident Crohn\u2019s disease in US women. Ann Rheum Dis. 2013;72(7):1200\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1179_CR63","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1136\/annrheumdis-2017-212328","volume":"77","author":"R Charlton","year":"2018","unstructured":"Charlton R, Green A, Shaddick G, Snowball J, Nightingale A, Tillett W, Smith CH, McHugh N, PROMPT study group. Risk of uveitis and inflammatory bowel disease in people with psoriatic arthritis: a population-based cohort study. Ann Rheum Dis. 2018;77(2):277\u201380.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1179_CR64","doi-asserted-by":"publisher","first-page":"e002781","DOI":"10.1136\/rmdopen-2022-002781","volume":"9","author":"DA De Vicente","year":"2023","unstructured":"De Vicente DA, Sanchez-Bilbao L, Calvo-R\u00edo V, Mart\u00ednez-L\u00f3pez D, Herrero-Morant A, Gal\u00edndez-Agirregoikoa E, Gonzalez-Mazon I, Barroso-Garc\u00eda N, Palmou-Fontana N, Gonzalez-Gay MA, Hern\u00e1ndez JL, Blanco R. Uveitis in psoriatic arthritis: study of 406 patients in a single university center and literature review. RMD Open. 2023;9(1):e002781.","journal-title":"RMD Open"},{"issue":"24","key":"1179_CR65","doi-asserted-by":"publisher","first-page":"7457","DOI":"10.3390\/jcm11247457","volume":"11","author":"W Pytrus","year":"2022","unstructured":"Pytrus W, Akutko K, Pytrus T, Turno-Kr\u0119cicka A. A Review of Ophthalmic Complications in Inflammatory Bowel Diseases. J Clin Med. 2022;11(24):7457.","journal-title":"J Clin Med"},{"issue":"4","key":"1179_CR66","doi-asserted-by":"publisher","first-page":"e485","DOI":"10.1111\/aos.15793","volume":"102","author":"H Lin","year":"2024","unstructured":"Lin H, Zhang J, Liang C, Wu D, Tan Y, Luo L, Liu Z. Differences in the prevalence of uveitis between Crohn\u2019s disease and ulcerative colitis: A systematic review and meta-analysis. Acta Ophthalmol. 2024;102(4):e485\u201392.","journal-title":"Acta Ophthalmol"},{"issue":"10","key":"1179_CR67","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1002\/art.40551","volume":"70","author":"G Varkas","year":"2018","unstructured":"Varkas G, Vastesaeger N, Cypers H, Colman R, Renson T, Praet LV, Carron P, Raeman F, Devinck M, Gyselbrecht L, Corluy L, Piette Y, Lenaerts J, Thevissen K, Vanneuville B, Bosch FVD, Elewaut D. Association of Inflammatory Bowel Disease and Acute Anterior Uveitis, but Not Psoriasis, With Disease Duration in Patients With Axial Spondyloarthritis: Results From Two Belgian Nationwide Axial Spondyloarthritis Cohorts. Arthritis Rheumatol. 2018;70(10):1588\u201396.","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"1179_CR68","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/acr.24174","volume":"73","author":"LC Coates","year":"2021","unstructured":"Coates LC, Baraliakos X, Blanco FJ, Blanco-Morales EA, Braun J, Chandran V, Fernandez-Sueiro JL, FitzGerald O, Gallagher P, Gladman DD, Gubar E, Korotaeva T, Loginova E, Lubrano E, Mulero J, Pinto-Tasende J, Queiro R, Sanz Sanz J, Szentpetery A, Helliwell PS. The Phenotype of Axial Spondyloarthritis: Is It Dependent on HLA-B27 Status\u202f? Arthritis Care Res (Hoboken). 2021;73(6):856\u201360.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1179_CR69","doi-asserted-by":"crossref","unstructured":"Wellcome Trust Case Control Consortium; Australo-Anglo-American Spondylitis Consortium (TASC); ... Brown M. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007;39 (11):1329\u201337.","DOI":"10.1038\/ng.2007.17"},{"key":"1179_CR70","doi-asserted-by":"crossref","unstructured":"Australo-Anglo-American Spondyloarthritis Consortium (TASC), Wellcome Trust Case Control Consortium 2 (WTCCC2), Evans DM, Spencer CC, Pointon JJ, Su Z, Harvey D, Kochan G, Oppermann U, Dilthey A, Pirinen M. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.\u00a0Nat Genet.\u00a02011:43(8):761\u20137.","DOI":"10.1038\/ng0911-919a"},{"issue":"12","key":"1179_CR71","doi-asserted-by":"publisher","first-page":"671306","DOI":"10.3389\/fgene.2021.671306","volume":"3","author":"F Costantino","year":"2021","unstructured":"Costantino F, Mambu Mambueni H, Said-Nahal R, Garchon HJ, Breban M. What Have We Learned From Family-Based Studies About Spondyloarthritis? Front Genet. 2021;3(12):671306.","journal-title":"Front Genet"},{"issue":"9","key":"1179_CR72","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1002\/art.24749","volume":"60","author":"K Hemminki","year":"2009","unstructured":"Hemminki K, Li X, Sundquist K, Sundquist J. Shared familial aggregation of susceptibility to autoimmune diseases. Arthritis Rheum. 2009;60(9):2845\u20137.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"1179_CR73","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1002\/art.22812","volume":"56","author":"B Thjodleifsson","year":"2007","unstructured":"Thjodleifsson B, Geirsson AJ, Bj\u00f6rnsson S, Bjarnason I. A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland. Arthritis Rheum. 2007;56(8):2633\u20139.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1179_CR74","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1136\/ard.2005.041103","volume":"65","author":"E Jaakkola","year":"2006","unstructured":"Jaakkola E, Herzberg I, Laiho K, Barnardo MC, Pointon JJ, Kauppi M, Kaarela K, Tuomilehto-Wolf E, Tuomilehto J, Wordsworth BP, Brown MA. Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis. Ann Rheum Dis. 2006;65(6):775\u201380.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"1179_CR75","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1002\/art.1780401015","volume":"40","author":"MA Brown","year":"1997","unstructured":"Brown MA, Kennedy LG, MacGregor AJ, Darke C, Duncan E, Shatford JL, Taylor A, Calin A, Wordsworth P. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum. 1997;40(10):1823\u20138.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1179_CR76","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1136\/ard.59.11.883","volume":"59","author":"MA Brown","year":"2000","unstructured":"Brown MA, Laval SH, Brophy S, Calin A. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis. 2000;59(11):883\u20136.","journal-title":"Ann Rheum Dis"},{"key":"1179_CR77","doi-asserted-by":"crossref","unstructured":"Ellinghaus D, .. International IBD Genetics Consortium (IIBDGC); International Genetics of Ankylosing Spondylitis Consortium (IGAS); International PSC Study Group (IPSCSG); Genetic Analysis of Psoriasis Consortium (GAPC); Psoriasis Association Genetics Extension (PAGE). Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat Genet 2016; 48(5):510-8. Epub 2016 Mar 14","DOI":"10.1038\/ng.3528"},{"issue":"11","key":"1179_CR78","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41584-022-00833-0","volume":"18","author":"R Stovall","year":"2022","unstructured":"Stovall R, van der Horst-Bruinsma IE, Liu SH, Rusman T, Gensler LS. Sexual dimorphism in the prevalence, manifestation and outcomes of axial spondyloarthritis. Nat Rev Rheumatol. 2022;18(11):657\u201369.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"1179_CR79","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/ard.2004.020503","volume":"64","author":"MC Creemers","year":"2005","unstructured":"Creemers MC, Franssen MJ, van\u2019t Hof MA, Gribnau FW, van de Putte LB, van Riel PL. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis. 2005;64(1):127\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1179_CR80","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13075-023-03173-w","volume":"25","author":"M Hallstr\u00f6m","year":"2023","unstructured":"Hallstr\u00f6m M, Klingberg E, Deminger A, Rehnman JB, Geijer M, Forsblad-d\u2019Elia H. Physical function and sex differences in radiographic axial spondyloarthritis: a cross-sectional analysis on Bath Ankylosing Spondylitis Functional Index. Arthritis Res Ther. 2023;25(1):182.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"1179_CR81","first-page":"315","volume":"28","author":"MM Ward","year":"2001","unstructured":"Ward MM, Kuzis S. Risk factors for work disability in patients with ankylosing spondylitis. J Rheumatol. 2001;28(2):315\u201321.","journal-title":"J Rheumatol"},{"issue":"5","key":"1179_CR82","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/art.21444","volume":"53","author":"MM Ward","year":"2005","unstructured":"Ward MM, Weisman MH, Davis JC Jr, Reveille JD. Risk factors for functional limitations in patients with long-standing ankylosing spondylitis. Arthritis Rheum. 2005;53(5):710\u20137.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1179_CR83","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1136\/ard.60.11.1033","volume":"60","author":"A Boonen","year":"2001","unstructured":"Boonen A, Chorus A, Miedema H, van der Heijde D, Landew\u00e9 R, Schouten H, van der Tempel H, van der Linden S. Withdrawal from labour force due to work disability in patients with ankylosing spondylitis. Ann Rheum Dis. 2001;60(11):1033\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"1179_CR84","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.1093\/rheumatology\/keaa175","volume":"59","author":"D Poddubnyy","year":"2020","unstructured":"Poddubnyy D, Weineck H, Diekhoff T, Redeker I, Gobejishvili N, Llop M, Rodriguez VR, Proft F, Protopopov M, Haibel H, Sieper J, Hermann KGA. Clinical and imaging characteristics of osteitis condensans ilii as compared with axial spondyloarthritis. Rheumatology (Oxford). 2020;59(12):3798\u2013806.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"1179_CR85","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1136\/annrheumdis-2013-203643","volume":"73","author":"P Jacques","year":"2014","unstructured":"Jacques P, Lambrecht S, Verheugen E, Pauwels E, Kollias G, Armaka M, Verhoye M, Van der Linden A, Achten R, Lories RJ, Elewaut D. Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells. Ann Rheum Dis. 2014;73(2):437\u201345.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1179_CR86","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1136\/annrheumdis-2015-207786","volume":"75","author":"V Navarro-Comp\u00e1n","year":"2016","unstructured":"Navarro-Comp\u00e1n V, Ramiro S, Landew\u00e9 R, Dougados M, Miceli-Richard C, Richette P, van der Heijde D. Disease activity is longitudinally related to sacroiliac inflammation on MRI in male patients with axial spondyloarthritis: 2-years of the DESIR cohort. Ann Rheum Dis. 2016;75(5):874\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1179_CR87","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1136\/annrheumdis-2016-210697","volume":"77","author":"V Navarro-Comp\u00e1n","year":"2018","unstructured":"Navarro-Comp\u00e1n V, Ramiro S, Landew\u00e9 R, Dougados M, Miceli-Richard C, Richette P, van der Heijde D. In patients with axial spondyloarthritis, inflammation on MRI of the spine is longitudi-nally related to disease activity only in men: 2 years of the axial spondyloarthritis DESIR cohort. Ann Rheum Dis. 2018;77(3):470\u20132.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1179_CR88","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/annrheumdis-2017-212378","volume":"77","author":"A Molt\u00f3","year":"2018","unstructured":"Molt\u00f3 A, Etcheto A, Gossec L, Boudersa N, Claudepierre P, Roux N, Lemeunier L, Martin A, Sparsa L, Coquerelle P, Soubrier M, Perrot S, Dougados M. Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers\u2019 effectiveness in axial spondyloarthritis: results of a prospective, multicentre study. Ann Rheum Dis. 2018;77(4):533\u201340.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1179_CR89","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/acr.25048","volume":"75","author":"C Fern\u00e1ndez-Carballido","year":"2023","unstructured":"Fern\u00e1ndez-Carballido C, Sanchez-Piedra C, Valls R, Garg K, S\u00e1nchez-Alonso F, Artigas L, Mas JM, Jovan\u00ed V, Manrique S, Campos C, Freire M, Mart\u00ednez-Gonz\u00e1lez O, Castrej\u00f3n I, Perella C, Coma M, van der Horst-Bruinsma IE. Female Sex, Age, and Unfavorable Response to Tumor Necrosis Factor Inhibitors in Patients With Axial Spondyloarthritis: Results of Statistical and Artificial Intelligence-Based Data Analyses of a National Multicenter Prospective Registry. Arthritis Care Res (Hoboken). 2023;75(1):115\u201324.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"1179_CR90","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/rheumatology\/kex318","volume":"57","author":"X Baraliakos","year":"2018","unstructured":"Baraliakos X, Regel A, Kiltz U, Menne HJ, Dybowski F, Igelmann M, Kalthoff L, Krause D, Saracbasi-Zender E, Schmitz-Bortz E, Braun J. Patients with fibromyalgia rarely fulfil classification criteria for axial spondyloarthritis. Rheumatology (Oxford). 2018;57(9):1541\u20137.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1179_CR91","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13075-021-02712-7","volume":"24","author":"J Braun","year":"2022","unstructured":"Braun J, Baraliakos X, B\u00fclow R, Schmidt CO, Richter A. Striking sex differences in magnetic resonance imaging findings in the sacroiliac joints in the population. Arthritis Res Ther. 2022;24(1):29.","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"1179_CR92","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/nrg2415","volume":"9","author":"C Ober","year":"2008","unstructured":"Ober C, Loisel DA, Gilad Y. Sex-specific genetic architecture of human disease. Nat Rev Genet. 2008;9(12):911\u201322.","journal-title":"Nat Rev Genet"},{"issue":"10","key":"1179_CR93","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626\u201338.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1179_CR94","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.it.2013.10.006","volume":"35","author":"JG Markle","year":"2014","unstructured":"Markle JG, Fish EN. SeXX matters in immunity. Trends Immunol. 2014;35(3):97\u2013104.","journal-title":"Trends Immunol"},{"issue":"5","key":"1179_CR95","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S1473-3099(10)70049-9","volume":"10","author":"SL Klein","year":"2010","unstructured":"Klein SL, Jedlicka A, Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis. 2010;10(5):338\u201349.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1179_CR96","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/trstmh\/tru167","volume":"109","author":"SL Klein","year":"2015","unstructured":"Klein SL, Marriott I, Fish EN. Sex-based differences in immune function and responses to vaccination. Trans R Soc Trop Med Hyg. 2015;109(1):9\u201315.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"7","key":"1179_CR97","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1097\/QAD.0b013e3280b0774a","volume":"21","author":"J Collazos","year":"2007","unstructured":"Collazos J, Asensi V, Cart\u00f3n JA. Sex differences in the clinical, immunological and virolo-gical parameters of HIV-infected patients treated with HAART. AIDS. 2007;21(7):835\u201343.","journal-title":"AIDS"},{"issue":"9","key":"1179_CR98","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3389\/fimmu.2018.01269","volume":"4","author":"MR Gubbels Bupp","year":"2018","unstructured":"Gubbels Bupp MR, Potluri T, Fink AL, Klein SL. The Confluence of Sex Hormones and Aging on Immunity. Front Immunol. 2018;4(9):1269.","journal-title":"Front Immunol"},{"issue":"33","key":"1179_CR99","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1146\/annurev-cellbio-100616-060718","volume":"6","author":"KL Flanagan","year":"2017","unstructured":"Flanagan KL, Fink AL, Plebanski M, Klein SL. Sex and Gender Differences in the Outcomes of Vaccination over the Life Course. Annu Rev Cell Dev Biol. 2017;6(33):577\u201399.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"5","key":"1179_CR100","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc.2016.30","volume":"16","author":"A Clocchiatti","year":"2016","unstructured":"Clocchiatti A, Cora E, Zhang Y, Dotto GP. Sexual dimorphism in cancer. Nat Rev Cancer. 2016;16(5):330\u20139.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"1179_CR101","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41577-020-0338-x","volume":"20","author":"P Aaby","year":"2020","unstructured":"Aaby P, Benn CS, Flanagan KL, Klein SL, Kollmann TR, Lynn DJ, Shann F. The non-specific and sex-differential effects of vaccines. Nat Rev Immunol. 2020;20(8):464\u201370.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1179_CR102","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/art.39464","volume":"68","author":"E Gracey","year":"2016","unstructured":"Gracey E, Yao Y, Green B, Qaiyum Z, Baglaenko Y, Lin A, Anton A, Ayearst R, Yip P, Inman RD. Sexual Dimorphism in the Th17 Signature of Ankylosing Spondylitis. Arthritis Rheumatol. 2016;68(3):679\u201389.","journal-title":"Arthritis Rheumatol"},{"key":"1179_CR103","doi-asserted-by":"crossref","unstructured":"Klein SL, Roberts CW. Sex and Gender Differences in Infection and Treatments for Infectious Diseases. Springer International Publishing) 2015.","DOI":"10.1007\/978-3-319-16438-0"},{"issue":"4","key":"1179_CR104","doi-asserted-by":"publisher","first-page":"e0249521","DOI":"10.1128\/spectrum.02495-21","volume":"10","author":"M Nam","year":"2022","unstructured":"Nam M, Yun SG, Kim SW, Kim CG, Cha JH, Lee C, Kang S, Park SG, Kim SB, Lee KB, Chung YS, Nam MH, Lee CK, Cho Y. Humoral and Cellular immune responses to vector, Mix-and-Match, or mRNA vaccines against SARS-CoV-2 and the relationship between the two immune responses. Microbiol Spectr. 2022;10(4):e0249521.","journal-title":"Microbiol Spectr"},{"issue":"1","key":"1179_CR105","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12967-023-03944-8","volume":"21","author":"J Chen","year":"2023","unstructured":"Chen J, Gao L, Wu X, Fan Y, Liu M, Peng L, Song J, Li B, Liu A, Bao F. BCG-induced trained immunity: history, mechanisms and potential applications. J Transl Med. 2023;21(1):106.","journal-title":"J Transl Med"},{"key":"1179_CR106","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41541-019-0124-6","volume":"4","author":"T Potluri","year":"2019","unstructured":"Potluri T, Fink AL, Sylvia KE, Dhakal S, Vermillion MS, Vom Steeg L, Deshpande S, Narasimhan H, Klein SL. Age-associated changes in the impact of sex steroids on influenza vaccine responses in males and females. NPJ Vaccines. 2019;4:29 (Erratum in: NPJ Vaccines 2019 Aug 12;4:35).","journal-title":"NPJ Vaccines"},{"issue":"18","key":"1179_CR107","doi-asserted-by":"publisher","first-page":"e180076","DOI":"10.1172\/JCI180076","volume":"134","author":"D Fairweather","year":"2024","unstructured":"Fairweather D, Beetler DJ, McCabe EJ, Lieberman SM. Mechanisms underlying sex differences in autoimmunity. J Clin Invest. 2024;134(18):e180076.","journal-title":"J Clin Invest"},{"key":"1179_CR108","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41576-018-0083-1","volume":"3","author":"EA Khramtsova","year":"2019","unstructured":"Khramtsova EA, Davis LK, Stranger BE. The role of sex in the genomics of\u00a0human complex traits. Nat Rev Genet. 2019;3:173\u201390 (Erratum in: Nat Rev Genet 2019 Aug; 20 (8):494).","journal-title":"Nat Rev Genet"},{"issue":"3","key":"1179_CR109","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.immuni.2020.08.003","volume":"53","author":"MJ Bunders","year":"2020","unstructured":"Bunders MJ, Altfeld M. Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions. Immunity. 2020;53(3):487\u201395.","journal-title":"Immunity"},{"issue":"4","key":"1179_CR110","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","volume":"184","author":"A Sette","year":"2021","unstructured":"Sette A, Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. 2021;184(4):861\u201380.","journal-title":"Cell"},{"issue":"8","key":"1179_CR111","doi-asserted-by":"publisher","first-page":"104717","DOI":"10.1016\/j.isci.2022.104717","volume":"25","author":"JM Schafer","year":"2022","unstructured":"Schafer JM, Xiao T, Kwon H, Collier K, Chang Y, Abdel-Hafiz H, Bolyard C, Chung D, Yang Y, Sundi D, Ma Q, Theodorescu D, Li X, Li Z. Sex-biased adaptive immune regulation in cancer development and therapy. iScience. 2022;25(8):104717.","journal-title":"iScience"},{"issue":"4","key":"1179_CR112","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/annweh\/wxx116","volume":"62","author":"M Bertin","year":"2018","unstructured":"Bertin M, Th\u00e9baud-Mony A, Counil E, Giscop93 study group. Do Women and Men Have the Same Patterns of Multiple Occupational Carcinogenic Exposures? Results from a Cohort of Cancer Patients. Ann Work Expo Health. 2018;62(4):450\u201364.","journal-title":"Ann Work Expo Health"},{"key":"1179_CR113","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1073\/pnas.1321060111","volume":"111","author":"D Furman","year":"2014","unstructured":"Furman D, Hejblum BP, Simon N, Jojic V, Dekker CL, Thi\u00e9baut R, Tibshirani RJ, Davis MM. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc Natl Acad Sci U S A. 2014;111:869\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"1179_CR114","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.3389\/fimmu.2020.01184","volume":"2","author":"I Ben-Batalla","year":"2020","unstructured":"Ben-Batalla I, Vargas-Delgado ME, von Amsberg G, Janning M, Loges S. Influence of Androgens on Immunity to Self and Foreign: Effects on Immunity and Cancer. Front Immunol. 2020;2(11):1184.","journal-title":"Front Immunol"},{"issue":"11","key":"1179_CR115","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.4049\/jimmunol.1501684","volume":"195","author":"M Griesbeck","year":"2015","unstructured":"Griesbeck M, Ziegler S, Laffont S, Smith N, Chauveau L, Tomezsko P, Sharei A, Kourjian G, Porichis F, Hart M, Palmer CD, Sirignano M, Beisel C, Hildebrandt H, C\u00e9nac C, Villani AC, Diefen-bach TJ, Le Gall S, Schwartz O, Herbeuval JP, Autran B, Gu\u00e9ry JC, Chang JJ, Altfeld M. Sex Differen-ces in Plasmacytoid Dendritic Cell Levels of IRF5 Drive Higher IFN-\u03b1 Production in Women. J Immunol. 2015;195(11):5327\u201336.","journal-title":"J Immunol"},{"issue":"5","key":"1179_CR116","doi-asserted-by":"publisher","first-page":"E856","DOI":"10.1152\/ajpendo.00484.2005","volume":"290","author":"ST Page","year":"2006","unstructured":"Page ST, Plymate SR, Bremner WJ, Matsumoto AM, Hess DL, Lin DW, Amory JK, Nelson PS, Wu JD. Effect of medical castration on CD4+ CD25+ T cells, CD8+ T cell IFN-gamma expression, and NK cells: a physiological role for testosterone and\/or its metabolites. Am J Physiol Endocrinol Metab. 2006;290(5):E856\u201363.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"1179_CR117","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1210\/me.2008-0106","volume":"23","author":"S Altuwaijri","year":"2009","unstructured":"Altuwaijri S, Chuang KH, Lai KP, Lai JJ, Lin HY, Young FM, Bottaro A, Tsai MY, Zeng WP, Chang HC, Yeh S, Chang C. Susceptibility to autoimmunity and B cell resistance to apoptosis in mice lacking androgen receptor in B cells. Mol Endocrinol. 2009;23(4):444\u201353 (Erratum in: Endocrinology. 2020 Sep 1;161(9): bqaa118).","journal-title":"Mol Endocrinol"},{"issue":"5\u20136","key":"1179_CR118","first-page":"567","volume":"58","author":"G Afshan","year":"2012","unstructured":"Afshan G, Afzal N, Qureshi S. CD4+CD25(hi) regulatory T cells in healthy males and females mediate gender difference in the prevalence of autoimmune diseases. Clin Lab. 2012;58(5\u20136):567\u201371.","journal-title":"Clin Lab"},{"issue":"2","key":"1179_CR119","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cellimm.2011.10.009","volume":"272","author":"M Abdullah","year":"2012","unstructured":"Abdullah M, Chai PS, Chong MY, Tohit ER, Ramasamy R, Pei CP, Vidyadaran S. Gender effect on in vitro lymphocyte subset levels of healthy individuals. Cell Immunol. 2012;272(2):214\u20139 (Epub 2011 Oct 25).","journal-title":"Cell Immunol"},{"issue":"13","key":"1179_CR120","doi-asserted-by":"publisher","first-page":"945762","DOI":"10.3389\/fimmu.2022.945762","volume":"24","author":"KC Dodd","year":"2022","unstructured":"Dodd KC, Menon M. Sex bias in lymphocytes: Implications for autoimmune diseases. Front Immunol. 2022;24(13):945762.","journal-title":"Front Immunol"},{"issue":"5","key":"1179_CR121","doi-asserted-by":"publisher","first-page":"R104","DOI":"10.1186\/ar2496","volume":"10","author":"X Baraliakos","year":"2008","unstructured":"Baraliakos X, Listing J, Rudwaleit M, Sieper J, Braun J. The relationship between inflammation and new bone formation in patients with ankylosing spondylitis. Arthritis Res Ther. 2008;10(5):R104.","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"1179_CR122","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1136\/annrheumdis-2013-203425","volume":"73","author":"X Baraliakos","year":"2014","unstructured":"Baraliakos X, Heldmann F, Callhoff J, Listing J, Appelboom T, Brandt J, van den Bosch F, Breban M, Burmester G, Dougados M, Emery P, Gaston H, Grunke M, Van Der Horst-Bruinsma IE, Landew\u00e9 R, Leirisalo-Repo M, Sieper J, De Vlam K, Pappas D, Kiltz U, van der Heijde D, Braun J. Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography. Ann Rheum Dis. 2014;73(10):1819\u201325.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1179_CR123","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1136\/annrheumdis-2014-205178","volume":"73","author":"S Ramiro","year":"2014","unstructured":"Ramiro S, van der Heijde D, van Tubergen A, Stolwijk C, Dougados M, van den Bosch F, Landew\u00e9 R. Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort. Ann Rheum Dis. 2014;73(8):1455\u201361.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1179_CR124","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1136\/ard.2009.124206","volume":"69","author":"P Machado","year":"2010","unstructured":"Machado P, Landew\u00e9 R, Braun J, Hermann KG, Baker D, van der Heijde D. Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis. Ann Rheum Dis. 2010;69(8):1465\u201370.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1179_CR125","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/rheumatology\/key128","volume":"58","author":"D van der Heijde","year":"2019","unstructured":"van der Heijde D, Braun J, Deodhar A, Baraliakos X, Landew\u00e9 R, Richards HB, Porter B, Readie A. Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis. Rheumatology (Oxford). 2019;58(3):388\u2013400.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"1179_CR126","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1136\/annrheumdis-2018-213393","volume":"77","author":"T Diekhoff","year":"2018","unstructured":"Diekhoff T, Greese J, Sieper J, Poddubnyy D, Hamm B, Hermann KA. Improved detection of erosions in the sacroiliac joints on MRI with volumetric interpolated breath-hold examination (VIBE): results from the SIMACT study. Ann Rheum Dis. 2018;77(11):1585\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1179_CR127","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/art.41595","volume":"73","author":"X Baraliakos","year":"2021","unstructured":"Baraliakos X, Ghadir A, Fruth M, Kiltz U, Redeker I, Braun J. Which Magnetic Resonance Imaging Lesions in the Sacroiliac Joints Are Most Relevant for Diagnosing Axial Spondyloarthritis\u202f? A Prospective Study Comparing Rheumatologists\u2019 Evaluations With Radiologists\u2019 Findings. Arthritis Rheumatol. 2021;73(5):800\u20135.","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"1179_CR128","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1002\/art.30393","volume":"63","author":"P Chiowchanwisawakit","year":"2011","unstructured":"Chiowchanwisawakit P, Lambert RG, Conner-Spady B, Maksymowych WP. Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis. Arthritis Rheum. 2011;63(8):2215\u201325.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1179_CR129","doi-asserted-by":"publisher","first-page":"e003118","DOI":"10.1136\/rmdopen-2023-003118","volume":"9","author":"R Stal","year":"2023","unstructured":"Stal R, Ramiro S, van der Heijde D, van Gaalen FA, Baraliakos X, Machado PM, de Hooge M, van den Berg R, Reijnierse M, Braun J, Landew\u00e9 R, Sepriano A. Do fatty lesions explain the effect of inflammation on new syndesmophytes in patients with radiographic axial spondylo-arthritis\u202f? Results from the SIAS cohort and ASSERT trial. RMD Open. 2023;9(3):e003118.","journal-title":"RMD Open"},{"issue":"3","key":"1179_CR130","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/annrheumdis-2017-212553","volume":"77","author":"F de Bruin","year":"2018","unstructured":"de Bruin F, de Koning A, van den Berg R, Baraliakos X, Braun J, Ramiro S, van Gaalen FA, Reijnierse M, van der Heijde D. Development of the CT Syndesmophyte Score (CTSS) in patients with ankylosing spondylitis: data from the SIAS cohort. Ann Rheum Dis. 2018;77(3):371\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1179_CR131","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1136\/annrheumdis-2017-211989","volume":"77","author":"A de Koning","year":"2018","unstructured":"de Koning A, de Bruin F, van den Berg R, Ramiro S, Baraliakos X, Braun J, van Gaalen FA, Reijnierse M, van der Heijde D. Low-dose CT detects more progression of bone formation in comparison to conventional radiography in patients with ankylosing spondylitis: results from the SIAS cohort. Ann Rheum Dis. 2018;77(2):293\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1179_CR132","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1148\/radiol.2020201537","volume":"298","author":"LBO Jans","year":"2021","unstructured":"Jans LBO, Chen M, Elewaut D, Van den Bosch F, Carron P, Jacques P, Wittoek R, Jaremko JL, Herregods N. MRI-based Synthetic CT in the Detection of Structural Lesions in Patients with Suspected Sacroiliitis: Comparison with MRI. Radiology. 2021;298(2):343\u20139.","journal-title":"Radiology"},{"key":"1179_CR133","doi-asserted-by":"crossref","unstructured":"Krabbe S, M\u00f8ller JM, Hadsbjerg AEF, Ewald A, Hangaard S, Pedersen SJ, \u00d8stergaard M. Detection of structural lesions of the sacroiliac joints in patients with spondyloarthritis: A comparison of T1-weighted 3D spoiled gradient echo MRI and MRI-based synthetic CT versus T1-weighted turbo spin echo MRI. Skeletal Radiol. 2024 Apr 9. Epub ahead of print.","DOI":"10.1007\/s00256-024-04669-5"},{"key":"1179_CR134","doi-asserted-by":"crossref","unstructured":"Gensler LS, Jans L, Majumdar S, Poddubnyy D. Unmet Needs in Spondyloarthritis: Imaging in Axial Spondyloarthritis. J Rheumatol 2024; jrheum.2024\u20130937","DOI":"10.3899\/jrheum.2024-0937"},{"issue":"11","key":"1179_CR135","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1136\/annrheumdis-2020-219585","volume":"80","author":"A Molto","year":"2021","unstructured":"Molto A, L\u00f3pez-Medina C, Van den Bosch FE, Boonen A, Webers C, Dernis E, van Gaalen FA, Soubrier M, Claudepierre P, Baillet A, Starmans-Kool M, Spoorenberg A, Jacques P, Carron P, Joos R, Lenaerts J, Gossec L, Pouplin S, Ruyssen-Witrand A, Sparsa L, van Tubergen A, van der Heijde D, Dougados M. Efficacy of a tight-control and treat-to-target strategy in axial spondylo-arthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial. Ann Rheum Dis. 2021;80(11):1436\u201344.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1179_CR136","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/art.1780380407","volume":"38","author":"J Braun","year":"1995","unstructured":"Braun J, Bollow M, Neure L, Seipelt E, Seyrekbasan F, Herbst H, Eggens U, Distler A, Sieper J. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum. 1995;38(4):499\u2013505.","journal-title":"Arthritis Rheum"},{"issue":"9313","key":"1179_CR137","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/S0140-6736(02)08215-6","volume":"359","author":"J Braun","year":"2002","unstructured":"Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W, Gromnica-Ihle E, Kellner H, Krause A, Schneider M, S\u00f6rensen H, Zeidler H, Thriene W, Sieper J. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet. 2002;359(9313):1187\u201393.","journal-title":"Lancet"},{"issue":"18","key":"1179_CR138","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJMoa012664","volume":"346","author":"JD Gorman","year":"2002","unstructured":"Gorman JD, Sack KE, Davis JC Jr. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med. 2002;346(18):1349\u201356.","journal-title":"N Engl J Med"},{"issue":"9227","key":"1179_CR139","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0140-6736(00)02530-7","volume":"356","author":"PJ Mease","year":"2000","unstructured":"Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet. 2000;356(9227):385\u201390.","journal-title":"Lancet"},{"issue":"15","key":"1179_CR140","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","volume":"337","author":"SR Targan","year":"1997","unstructured":"Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, DeWoody KL, Schaible TF, Rutgeerts PJ. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn\u2019s disease. Crohn\u2019s Disease cA2 Study Group. N Engl J Med. 1997;337(15):1029\u201335.","journal-title":"N Engl J Med"},{"issue":"9244","key":"1179_CR141","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/S0140-6736(00)03239-6","volume":"356","author":"F van den Bosch","year":"2000","unstructured":"van den Bosch F, Kruithof E, De Vos M, De Keyser F, Mielants H. Crohn\u2019s disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms. Lancet. 2000;356(9244):1821\u20132.","journal-title":"Lancet"},{"issue":"4","key":"1179_CR142","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/art.24408","volume":"60","author":"N Barkham","year":"2009","unstructured":"Barkham N, Keen HI, Coates LC, O\u2019Connor P, Hensor E, Fraser AD, Cawkwell LS, Bennett A, McGonagle D, Emery P. Clinical and imaging efficacy of infliximab in HLA-B27-positive patients with magnetic resonance imaging-determined early sacroiliitis. Arthritis Rheum. 2009;60(4):946\u201354.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"1179_CR143","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1002\/art.21913","volume":"54","author":"D van der Heijde","year":"2006","unstructured":"van der Heijde D, Kivitz A, Schiff MH, Sieper J, Dijkmans BA, Braun J, Dougados M, Reveille JD, Wong RL, Kupper H, Davis JC Jr, ATLAS Study Group. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2006;54(7):2136\u201346.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1179_CR144","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1002\/art.23969","volume":"58","author":"RD Inman","year":"2008","unstructured":"Inman RD, Davis JC Jr, Dv H, Diekman L, Sieper J, Kim SI, Mack M, Han J, Visvanathan S, Xu Z, Hsu B, Beutler A, Braun J. Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial. Arthritis Rheum. 2008;58(11):3402\u201312.","journal-title":"Arthritis Rheum"},{"issue":"26","key":"1179_CR145","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","volume":"373","author":"D Baeten","year":"2015","unstructured":"Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P, Deodhar A, Porter B, Martin R, Andersson M, Mpofu S, Richards HB, MEASURE 1 Study Group; MEASURE 2 Study Group. Secukinumab, an Interleukin-17A Inhibitor Ankylosing Spondylitis. N Engl J Med. 2015;373(26):2534\u201348.","journal-title":"N Engl J Med"},{"issue":"10163","key":"1179_CR146","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1016\/S0140-6736(18)31946-9","volume":"392","author":"D van der Heijde","year":"2018","unstructured":"van der Heijde D, Cheng-Chung Wei J, Dougados M, Mease P, Deodhar A, Maksymowych WP, Van den Bosch F, Sieper J, Tomita T, Landew\u00e9 R, Zhao F, Krishnan E, Adams DH, Pangallo B, Carlier H, COAST-V study group. Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial. Lancet. 2018;392(10163):2441\u201351.","journal-title":"Lancet"},{"key":"1179_CR147","doi-asserted-by":"crossref","unstructured":"van der Heijde D, Gensler LS, Deodhar A, Baraliakos X, Poddubnyy D, Kivitz A, Farmer MK, Baeten D, Goldammer N, Coarse J, Oortgiesen M, Dougados M. Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study. Ann Rheum Dis 2020; 79(5): 595\u2013604. Epub 2020 Apr 6. Erratum in: Ann Rheum Dis 2020 Sep; 79(9):e121. Erratum in: Ann Rheum Dis 2021 Nov; 80(11):e186.","DOI":"10.1136\/annrheumdis-2020-216980"},{"issue":"2","key":"1179_CR148","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa2102383","volume":"385","author":"K Reich","year":"2021","unstructured":"Reich K, Warren RB, Lebwohl M, Gooderham M, Strober B, Langley RG, Paul C, De Cuyper D, Vanvoorden V, Madden C, Cioffi C, Peterson L, Blauvelt A. Bimekizumab versus Secukinumab in Plaque Psoriasis. N Engl J Med. 2021;385(2):142\u201352.","journal-title":"N Engl J Med"},{"issue":"7","key":"1179_CR149","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1056\/NEJMra1909094","volume":"385","author":"G Schett","year":"2021","unstructured":"Schett G, McInnes IB, Neurath MF. Reframing Immune-Mediated Inflammatory Diseases through Signature Cytokine Hubs. N Engl J Med. 2021;385(7):628\u201339.","journal-title":"N Engl J Med"},{"issue":"2","key":"1179_CR150","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1136\/annrheumdis-2012-202646","volume":"73","author":"IB McInnes","year":"2014","unstructured":"McInnes IB, Sieper J, Braun J, Emery P, van der Heijde D, Isaacs JD, Dahmen G, Wollenhaupt J, Schulze-Koops H, Kogan J, Ma S, Schumacher MM, Bertolino AP, Hueber W, Tak PP. Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial. Ann Rheum Dis. 2014;73(2):349\u201356.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1179_CR151","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/annrheumdis-2016-209709","volume":"76","author":"PJ Mease","year":"2017","unstructured":"Mease PJ, van der Heijde D, Ritchlin CT, Okada M, Cuchacovich RS, Shuler CL, Lin CY, Braun DK, Lee CH, Gladman DD, SPIRIT-P1 Study Group. Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from a 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1. Ann Rheum Dis. 2017;76(1):79\u201387.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1179_CR152","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1136\/annrheumdis-2017-212127","volume":"77","author":"S Glatt","year":"2018","unstructured":"Glatt S, Baeten D, Baker T, Griffiths M, Ionescu L, Lawson ADG, Maroof A, Oliver R, Popa S, Strimenopoulou F, Vajjah P, Watling MIL, Yeremenko N, Miossec P, Shaw S. Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation. Ann Rheum Dis. 2018;77(4):523\u201332.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"1179_CR153","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1136\/annrheumdis-2018-213328","volume":"77","author":"D Baeten","year":"2018","unstructured":"Baeten D, \u00d8stergaard M, Wei JC, Sieper J, J\u00e4rvinen P, Tam LS, Salvarani C, Kim TH, Solinger A, Datsenko Y, Pamulapati C, Visvanathan S, Hall DB, Aslanyan S, Scholl P, Padula SJ. Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study. Ann Rheum Dis. 2018;77(9):1295\u2013302.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1179_CR154","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/art.40728","volume":"71","author":"A Deodhar","year":"2019","unstructured":"Deodhar A, Gensler LS, Sieper J, Clark M, Calderon C, Wang Y, Zhou Y, Leu JH, Campbell K, Sweet K, Harrison DD, Hsia EC, van der Heijde D. Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis. Arthritis Rheumatol. 2019;71(2):258\u201370.","journal-title":"Arthritis Rheumatol"},{"issue":"16","key":"1179_CR155","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1056\/NEJMoa1203572","volume":"367","author":"WJ Sandborn","year":"2012","unstructured":"Sandborn WJ, Gasink C, Gao LL, Blank MA, Johanns J, Guzzo C, Sands BE, Hanauer SB, Targan S, Rutgeerts P, Ghosh S, de Villiers WJ, Panaccione R, Greenberg G, Schreiber S, Lichtiger S, Feagan BG, CERTIFI Study Group. Ustekinumab induction and maintenance therapy in refractory Crohn\u2019s disease. N Engl J Med. 2012;367(16):1519\u201328.","journal-title":"N Engl J Med"},{"key":"1179_CR156","doi-asserted-by":"crossref","unstructured":"Sandborn WJ, D'Haens GR, Reinisch W, Pan\u00e9s J, Chan D, Gonzalez S, Weisel K, Germinaro M, Frustaci ME, Yang Z, Adedokun OJ, Han C, Panaccione R, Hisamatsu T, Danese S, Rubin DT, Sands BE, Afzali A, Andrews JM, Feagan BG; GALAXI-1 Investigators. Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study. Gastroenterology 2022;162(6): 1650\u20131664.e8. Erratum in: Gastroenterology 2023 Dec;165(6):1588.","DOI":"10.1053\/j.gastro.2022.01.047"},{"key":"1179_CR157","doi-asserted-by":"crossref","unstructured":"Gottlieb A, Menter A, Mendelsohn A, Shen YK, Li S, Guzzo C, Fretzin S, Kunynetz R, Kavanaugh A. Ustekinumab, a human interleukin 12\/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial. Lancet. 2009; 373(9664): 633-40. Erratum in: Lancet. 2009 Apr 18;373(9672):1340. Erratum in: Lancet. 2010 Nov 6;376(9752):1542","DOI":"10.1016\/S0140-6736(09)60140-9"},{"issue":"10136","key":"1179_CR158","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/S0140-6736(18)30952-8","volume":"391","author":"A Deodhar","year":"2018","unstructured":"Deodhar A, Gottlieb AB, Boehncke WH, Dong B, Wang Y, Zhuang Y, Barchuk W, Xu XL, Hsia EC, CNTO1959PSA2001 Study Group. Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study. Lancet. 2018;391(10136):2213\u201324.","journal-title":"Lancet"},{"issue":"2","key":"1179_CR159","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/rheumatology\/key070","volume":"58","author":"DJ Veale","year":"2019","unstructured":"Veale DJ, McGonagle D, McInnes IB, Krueger JG, Ritchlin CT, Elewaut D, Kanik KS, Hendrikx T, Berstein G, Hodge J, Telliez JB. The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis. Rheumatology (Oxford). 2019;58(2):197\u2013205.","journal-title":"Rheumatology (Oxford)"},{"issue":"16","key":"1179_CR160","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1056\/NEJMoa1615975","volume":"377","author":"P Mease","year":"2017","unstructured":"Mease P, Hall S, FitzGerald O, van der Heijde D, Merola JF, Avila-Zapata F, Cie\u015blak D, Graham D, Wang C, Menon S, Hendrikx T, Kanik KS. Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis. N Engl J Med. 2017;377(16):1537\u201350.","journal-title":"N Engl J Med"},{"issue":"8","key":"1179_CR161","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/annrheumdis-2016-210322","volume":"76","author":"D van der Heijde","year":"2017","unstructured":"van der Heijde D, Deodhar A, Wei JC, Drescher E, Fleishaker D, Hendrikx T, Li D, Menon S, Kanik KS. Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study. Ann Rheum Dis. 2017;76(8):1340\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"13","key":"1179_CR162","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMoa2022516","volume":"384","author":"IB McInnes","year":"2021","unstructured":"McInnes IB, Anderson JK, Magrey M, Merola JF, Liu Y, Kishimoto M, Jeka S, Pacheco-Tena C, Wang X, Chen L, Zueger P, Liu J, Pangan AL, Behrens F. Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis. N Engl J Med. 2021;384(13):1227\u201339.","journal-title":"N Engl J Med"},{"issue":"10214","key":"1179_CR163","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/S0140-6736(19)32534-6","volume":"394","author":"D van der Heijde","year":"2019","unstructured":"van der Heijde D, Song IH, Pangan AL, Deodhar A, van den Bosch F, Maksymowych WP, Kim TH, Kishimoto M, Everding A, Sui Y, Wang X, Chu AD, Sieper J. Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2\/3 trial. Lancet. 2019;394(10214):2108\u201317.","journal-title":"Lancet"},{"issue":"10162","key":"1179_CR164","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1016\/S0140-6736(18)32463-2","volume":"392","author":"D van der Heijde","year":"2018","unstructured":"van der Heijde D, Baraliakos X, Gensler LS, Maksymowych WP, Tseluyko V, Nadashkevich O, Abi-Saab W, Tasset C, Meuleners L, Besuyen R, Hendrikx T, Mozaffarian N, Liu K, Greer JM, Deodhar A, Landew\u00e9 R. Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial. Lancet. 2018;392(10162):2378\u201387.","journal-title":"Lancet"},{"issue":"10292","key":"1179_CR165","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/S0140-6736(21)00666-8","volume":"397","author":"BG Feagan","year":"2021","unstructured":"Feagan BG, Danese S, Loftus EV Jr, Vermeire S, Schreiber S, Ritter T, Fogel R, Mehta R, Nijhawan S, Kempi\u0144ski R, Filip R, Hospodarskyy I, Seidler U, Seibold F, Beales ILP, Kim HJ, McNally J, Yun C, Zhao S, Liu X, Hsueh CH, Tasset C, Besuyen R, Watanabe M, Sandborn WJ, Rogler G, Hibi T, Peyrin-Biroulet L. Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b\/3 double-blind, randomised, placebo-controlled trial. Lancet. 2021;397(10292):2372\u201384.","journal-title":"Lancet"},{"issue":"9","key":"1179_CR166","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa2031994","volume":"384","author":"AC Kalil","year":"2021","unstructured":"Kalil AC, Patterson TF, Mehta AK, Tomashek KM, Wolfe CR, Ghazaryan V, Marconi VC, Ruiz-Palacios GM, Hsieh L, Kline S, Tapson V, Iovine NM, Jain MK, Sweeney DA, El Sahly HM, Branche AR, Regalado Pineda J, Lye DC, Sandkovsky U, Luetkemeyer AF, Cohen SH, Finberg RW, Jackson PEH, Taiwo B, Paules CI, Arguinchona H, Erdmann N, Ahuja N, Frank M, Oh MD, Kim ES, Tan SY, Mularski RA, Nielsen H, Ponce PO, Taylor BS, Larson L, Rouphael NG, Saklawi Y, Cantos VD, Ko ER, Engemann JJ, Amin AN, Watanabe M, Billings J, Elie MC, Davey RT, Burgess TH, Ferreira J, Green M, Makowski M, Cardoso A, de Bono S, Bonnett T, Proschan M, Deye GA, Dempsey W, Nayak SU, Dodd LE, Beigel JH, ACTT-2 Study Group Members. Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. N Engl J Med. 2021;384(9):795\u2013807.","journal-title":"N Engl J Med"},{"issue":"5","key":"1179_CR167","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/art.21790","volume":"54","author":"J Braun","year":"2006","unstructured":"Braun J, Landew\u00e9 R, Hermann KG, Han J, Yan S, Williamson P, van der Heijde D, ASSERT Study Group. Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study. Arthritis Rheum. 2006;54(5):1646\u201352.","journal-title":"Arthritis Rheum"},{"key":"1179_CR168","doi-asserted-by":"crossref","unstructured":"Molnar C, Scherer A, Baraliakos X, de Hooge M, Micheroli R, Exer P, Kissling RO, Tamborrini G, Wildi LM, Nissen MJ, Zufferey P, Bernhard J, Weber U, Landew\u00e9 RBM, van der Heijde D, Ciurea A; Rheumatologists of the Swiss Clinical Quality Management Program. TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis 2018; 77 (1): 63\u201369","DOI":"10.1136\/annrheumdis-2017-211544"},{"issue":"6","key":"1179_CR169","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1136\/annrheumdis-2012-203075","volume":"73","author":"J Braun","year":"2014","unstructured":"Braun J, Baraliakos X, Hermann KG, Deodhar A, van der Heijde D, Inman R, Beutler A, Zhou Y, Xu S, Hsu B. The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial. Ann Rheum Dis. 2014;73(6):1107\u201313.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"1179_CR170","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.3899\/jrheum.160003","volume":"43","author":"J Braun","year":"2016","unstructured":"Braun J, Baraliakos X, Hermann KG, Xu S, Hsu B. Serum C-reactive Protein Levels Demonstrate Predictive Value for Radiographic and Magnetic Resonance Imaging Outcomes in Patients with Active Ankylosing Spondylitis Treated with Golimumab. J Rheumatol. 2016;43(9):1704\u201312.","journal-title":"J Rheumatol"},{"issue":"1","key":"1179_CR171","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3899\/jrheum.181040","volume":"47","author":"J Braun","year":"2020","unstructured":"Braun J, Baraliakos X, Kiltz U, Kr\u00fcger K, Burmester GR, Wassenberg S, Thomas MH. Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor Inhibitor Therapy in Ankylosing Spondylitis: A German GO-NICE Study Subanalysis. J Rheumatol. 2020;47(1):35\u201341.","journal-title":"J Rheumatol"},{"issue":"6","key":"1179_CR172","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/1529-0131(200006)43:6<1346::AID-ANR18>3.0.CO;2-E","volume":"43","author":"J Brandt","year":"2000","unstructured":"Brandt J, Haibel H, Cornely D, Golder W, Gonzalez J, Reddig J, Thriene W, Sieper J, Braun J. Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab. Arthritis Rheum. 2000;43(6):1346\u201352.","journal-title":"Arthritis Rheum"},{"key":"1179_CR173","doi-asserted-by":"crossref","unstructured":"Baraliakos X, \u00d8stergaard M, Poddubnyy D, van der Heijde D, Deodhar A, Machado PM, Navarro-Comp\u00e1n V, Hermann KGA, Kishimoto M, Lee EY, Gensler LS, Kiltz U, Eigenmann MF, Pertel P, Readie A, Richards HB, Porter B, Braun J. Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head-to-Head Randomized Phase IIIb Study. Arthritis Rheumatol 2024.","DOI":"10.1002\/art.42852"},{"issue":"6","key":"1179_CR174","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1002\/art.21054","volume":"52","author":"A Wanders","year":"2005","unstructured":"Wanders A, Heijde Dv, Landew\u00e9 R, B\u00e9hier JM, Calin A, Olivieri I, Zeidler H, Dougados M. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum. 2005;52(6):1756\u201365.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"1179_CR175","first-page":"CD010952","volume":"2015","author":"FP Kroon","year":"2015","unstructured":"Kroon FP, van der Burg LR, Ramiro S, Landew\u00e9 RB, Buchbinder R, Falzon L, van der Heijde D. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis). Cochrane Database Syst Rev. 2015;2015(7):CD010952.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"1179_CR176","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1136\/ard-2023-224699","volume":"83","author":"F Proft","year":"2024","unstructured":"Proft F, Torgutalp M, Muche B, Rios Rodriguez V, Listing J, Protopopov M, Rademacher J, Haibel H, Spiller L, Weber AK, Verba M, Brandt-Juergens J, Kiltz U, Sieburg M, Jacki S, Sieper J, Poddubnyy D. Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial. Ann Rheum Dis. 2024;83(5):599\u2013607.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1179_CR177","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/art.24483","volume":"60","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Haibel H, Baraliakos X, Listing J, M\u00e4rker-Hermann E, Zeidler H, Braun J, Sieper J. The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum. 2009;60(3):717\u201327.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1179_CR178","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/art.33465","volume":"64","author":"D Poddubnyy","year":"2012","unstructured":"Poddubnyy D, Haibel H, Listing J, M\u00e4rker-Hermann E, Zeidler H, Braun J, Sieper J, Rudwaleit M. Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum. 2012;64(5):1388\u201398.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"1179_CR179","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1136\/annrheumdis-2012-203148","volume":"72","author":"D Poddubnyy","year":"2013","unstructured":"Poddubnyy D, Haibel H, Listing J, M\u00e4rker-Hermann E, Zeidler H, Braun J, Sieper J, Rudwaleit M. Cigarette smoking has a dose-dependent impact on progression of structural damage in the spine in patients with axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort (GESPIC). Ann Rheum Dis. 2013;72(8):1430\u20132.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1179_CR180","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jbspin.2011.01.013","volume":"78","author":"M Dougados","year":"2011","unstructured":"Dougados M, d\u2019Agostino MA, Benessiano J, Berenbaum F, Breban M, Claudepierre P, Combe B, Dargent-Molina P, Daur\u00e8s JP, Fautrel B, Feydy A, Goupille P, Leblanc V, Logeart I, Pham T, Richette P, Roux C, Rudwaleit M, Saraux A, Treluyer JM, van der Heijde D, Wendling D. The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients. Joint Bone Spine. 2011;78(6):598\u2013603.","journal-title":"Joint Bone Spine"},{"issue":"6","key":"1179_CR181","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1136\/annrheumdis-2012-201427","volume":"72","author":"M Blachier","year":"2013","unstructured":"Blachier M, Coutanceau B, Dougados M, Saraux A, Bastuji-Garin S, Ferkal S, Le Corvoisier P, Farrenq V, Poulain C, Ghaleh B, Canou\u00ef-Poitrine F, Claudepierre P. Does the site of magnetic resonance imaging abnormalities match the site of recent-onset inflammatory back pain? DESIR Cohort Ann Rheum Dis. 2013;72(6):979\u201385.","journal-title":"DESIR Cohort Ann Rheum Dis"},{"key":"1179_CR182","doi-asserted-by":"crossref","unstructured":"Dougados M, Etcheto A, Molto A, Alonso S, Bouvet S, Daur\u00e8s JP, Landais P, d'Agostino MA, Berenbaum F, Breban M, Claudepierre P, Combe B, Fautrel B, Feydy A, Goupille P, Richette P, Pham T, Roux C, Treluyer JM, Saraux A, van der Heijde D, Wendling D; DESIR cohort. Clinical presentation of patients suffering from recent onset chronic inflammatory back pain suggestive of spondyloarthritis: The DESIR cohort. Joint Bone Spine. 2015;82(5):345-51","DOI":"10.1016\/j.jbspin.2015.02.006"},{"issue":"2","key":"1179_CR183","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/annrheumdis-2019-216218","volume":"79","author":"C L\u00f3pez-Medina","year":"2020","unstructured":"L\u00f3pez-Medina C, Molto A, Claudepierre P, Dougados M. Clinical manifestations, disease activity and disease burden of radiographic versus non-radiographic axial spondyloarthritis over 5 years of follow-up in the DESIR cohort. Ann Rheum Dis. 2020;79(2):209\u201316.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1179_CR184","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1136\/annrheumdis-2015-207823","volume":"75","author":"M de Hooge","year":"2016","unstructured":"de Hooge M, van den Berg R, Navarro-Comp\u00e1n V, Reijnierse M, van Gaalen F, Fagerli K, Landew\u00e9 R, van Oosterhout M, Ramonda R, Huizinga T, van der Heijde D. Patients with chronic back pain of short duration from the SPACE cohort: which MRI structural lesions in the sacroiliac joints and inflammatory and structural lesions in the spine are most specific for axial spondyloarthritis? Ann Rheum Dis. 2016;75(7):1308\u201314.","journal-title":"Ann Rheum Dis"},{"key":"1179_CR185","doi-asserted-by":"crossref","unstructured":"Braun J. The Early Course of Radiographic Progression in Axial Spondyloarthritis: Have We Missed Something ? J Rheumatol 2024; jrheum. 2024\u20130807","DOI":"10.3899\/jrheum.2024-0807"},{"issue":"11","key":"1179_CR186","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1136\/ard.2011.151191","volume":"70","author":"G Bakland","year":"2011","unstructured":"Bakland G, Gran JT, Nossent JC. Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis. 2011;70(11):1921\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1179_CR187","doi-asserted-by":"publisher","first-page":"409","DOI":"10.7326\/M14-2470","volume":"163","author":"NN Haroon","year":"2015","unstructured":"Haroon NN, Paterson JM, Li P, Inman RD, Haroon N. Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality: A Population-Based Study. Ann Intern Med. 2015;163(6):409\u201316.","journal-title":"Ann Intern Med"},{"issue":"2","key":"1179_CR188","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.semarthrit.2019.07.012","volume":"50","author":"J Braun","year":"2020","unstructured":"Braun J, Baraliakos X, Westhoff T. Nonsteroidal anti-inflammatory drugs and cardiovas-cular risk - a matter of indication. Semin Arthritis Rheum. 2020;50(2):285\u20138.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"1179_CR189","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3899\/jrheum.150017","volume":"42","author":"N Haroon","year":"2015","unstructured":"Haroon N. Does a positive HLA-B27 test increase your risk of mortality? J Rheumatol. 2015;42(4):559\u201360.","journal-title":"J Rheumatol"},{"key":"1179_CR190","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0167-5699(90)90051-A","volume":"11","author":"R Benjamin","year":"1990","unstructured":"Benjamin R, Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today. 1990;11:137\u201342.","journal-title":"Immunol Today"},{"key":"1179_CR191","doi-asserted-by":"crossref","unstructured":"Navid F, Chen L, Bowness P, Colbert RA. HLA-B27 and spondyloarthritis: at the crossroads of innate and adaptive immunity. Nat Rev Rheumatol 2024.","DOI":"10.1038\/s41584-024-01189-3"},{"issue":"3","key":"1179_CR192","doi-asserted-by":"publisher","first-page":"e003102","DOI":"10.1136\/rmdopen-2023-003102","volume":"9","author":"J Braun","year":"2023","unstructured":"Braun J, Sieper J. Fifty years after the discovery of the association of HLA B27 with ankylosing spondylitis. RMD Open. 2023;9(3):e003102.","journal-title":"RMD Open"},{"issue":"12","key":"1179_CR193","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11926-023-01118-5","volume":"25","author":"MA Khan","year":"2023","unstructured":"Khan MA. HLA-B*27 and Ankylosing Spondylitis: 50 Years of Insights and Discoveries. Curr Rheumatol Rep. 2023;25(12):327\u201340.","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"1179_CR194","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1034\/j.1399-0039.2002.600404.x","volume":"60","author":"E May","year":"2002","unstructured":"May E, Dulphy N, Frauendorf E, Duchmann R, Bowness P, Lopez de Castro JA, Toubert A, M\u00e4rker-Hermann E. Conserved TCR beta chain usage in reactive arthritis; evidence for selection by a putative HLA-B27-associated autoantigen. Tissue Antigens. 2002;60(4):299\u2013308.","journal-title":"Tissue Antigens"},{"issue":"11","key":"1179_CR195","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1136\/ard-2024-225661","volume":"83","author":"J Braun","year":"2024","unstructured":"Braun J, M\u00e4rker-Hermann E, Rudwaleit M, Sieper J. HLA-B27 and the role of specific T cell receptors in the pathogenesis of spondyloarthritis. Ann Rheum Dis. 2024;83(11):1406\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1179_CR196","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/art.40028","volume":"69","author":"M Faham","year":"2017","unstructured":"Faham M, Carlton V, Moorhead M, Zheng J, Klinger M, Pepin F, Asbury T, Vignali M, Emerson RO, Robins HS, Ireland J, Baechler-Gillespie E, Inman RD. Discovery of T Cell Receptor \u03b2 Motifs Specific to HLA-B27-Positive Ankylosing Spondylitis by Deep Repertoire Sequence Analysis. Arthritis Rheumatol. 2017;69(4):774\u201384.","journal-title":"Arthritis Rheumatol"},{"issue":"7941","key":"1179_CR197","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41586-022-05501-7","volume":"612","author":"X Yang","year":"2022","unstructured":"Yang X, Garner LI, Zvyagin IV, Paley MA, Komech EA, Jude KM, Zhao X, Fernandes RA, Hassman LM, Paley GL, Savvides CS, Brackenridge S, Quastel MN, Chudakov DM, Bowness P, Yokoyama WM, McMichael AJ, Gillespie GM, Garcia KC. Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides. Nature. 2022;612(7941):771\u20137.","journal-title":"Nature"},{"issue":"11","key":"1179_CR198","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1038\/s41591-023-02613-z","volume":"29","author":"OV Britanova","year":"2023","unstructured":"Britanova OV, Lupyr KR, Staroverov DB, Shagina IA, Aleksandrov AA, Ustyugov YY, Somov DV, Klimenko A, Shostak NA, Zvyagin IV, Stepanov AV, Merzlyak EM, Davydov AN, Izraelson M, Egorov ES, Bogdanova EA, Vladimirova AK, Iakovlev PA, Fedorenko DA, Ivanov RA, Skvortsova VI, Lukyanov S, Chudakov DM. Targeted depletion of TRBV9+ T cells as immunotherapy in a patient with ankylosing spondylitis. Nat Med. 2023;29(11):2731\u20136.","journal-title":"Nat Med"},{"key":"1179_CR199","doi-asserted-by":"crossref","unstructured":"Effectiveness and safety of BCD-180, anti-TRBV9+\u00a0T-lymphocytes monoclonal antibody in patients with active radiographic axial spondyloarthritis: 36-week results of double-blind randomized placebo-controlled phase\u00a0II clinical study ELEFTA (in Russian). Nasonov EL et al. Rheumatology Science and Practice 2024; 62 (1): 65\u201380","DOI":"10.47360\/1995-4484-2024-65-80"},{"key":"1179_CR200","unstructured":"Braun J, Sieper J, Dougados M. The history of ankylosing spondylitis\/axial spondylo-arthritis \u2013 what is the driving force of new knowledge ? Semin Arthritis Rheum 2025, in press."}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-024-01179-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-024-01179-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-024-01179-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:02:48Z","timestamp":1770750168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-024-01179-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":200,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1179"],"URL":"https:\/\/doi.org\/10.1007\/s11926-024-01179-0","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"assertion":[{"value":"24 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by the author.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The author declares no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"15"}}